Crowdonomics
WatchlistPortfolio
Dex

Reg CF · SAFE · Nov 2022

ClosedReached targetReg CFSAFE
via Republic · last checked Oct 8, 2026View campaign
Raised
$164.7K / $1.2M max
13% of ceiling · target hit day 3
Investors
274
$601.1 avg
Valuation cap
$16M
cap, not an agreed valuation

Raised over time

Cumulative raisedInvestors
$164K$82K$0
2701350
Nov 15, 2022 · openedJan 15, 2023 · last reading
Target ($25K) hit — Nov 18, 2022, day 3Deadline Jan 14, 2023

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via Republic, last checked Oct 8, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2020–FY2021 · hover for source
$4K
−$145K
FY2020
$60K
−$423K
FY2021
RevenueNet income
Metric
FY2020 reviewed
FY2021 reviewed
Income statement
Revenue
$4,479
$59,514
Cost of goods sold
$202
$3,318
Gross margin
95%
94%
Net income
-$144,525
-$422,731
Taxes paid
$0
$0
Balance sheet
Cash
$476,338
$183,230
Accounts receivable
$0
$0
Total assets
$730,997
$353,319
Short-term debt
$429
$482
Long-term debt
$0
$0
Total liabilities
$429
$482
Other
Headcount
—
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Valuation cap$16M

Perks

Invest $500, receive free year of Dex premium$500+

Offering details

Target$25,000
Max$1,235,000
Min investment$100
OpenedNov 15, 2022
DeadlineJan 14, 2023
ClosedJan 14, 2023
Days active60

Links & provenance

Campaign pageSEC filing
Source: Manual
0001900769-22-000004
Last synced Aug 19, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.